# Funds Mgmt Core

> **NIH NIH U19** · WEILL MEDICAL COLL OF CORNELL UNIV · 2024 · $189,515

## Abstract

Weill Cornell Medicine (WMC)’s Research Business Management unit (RBM) will manage all
finances and administrative support for WCM’s proposed Autoimmunity Center of Excellence
(ACE) and serve as the ACE Funds Management Core (AFMC). RBM is staffed by an
experienced team of portfolio managers, each with a minimum of ten years of experience in pre
and post award administration. The unit is flexible, adaptable and easily scalable to need. Its
integration with central offices allows for maximum efficiencies in managing complex multisite
awards, an ideal model for the AFMC. WCM and the RBM unit is fully committed to supporting
legacy projects under the current Autoimmunity Centers of Excellence cycle and will work closely
with the current AFMC to ensure a seamless transition of all projects under WCM’s AFMC. As
needed, new agreements will be established between the WCM AFMC and participating sites to
provide continuing support.
Working in tandem with the WCM’s Office of Sponsored Research Administration, the WCM
AFMC will initiate, negotiate and execute all subawards, service agreements and related contracts
under the ACE Program. Using existing streamlined processes and systems, the WCM AFMC will
expeditiously process and manage all agreements under the program with full transparency to all
stakeholders. This will include tracking and reporting on agreement negotiations, sign off and
financial activities. Budget, invoicing and reporting tools will be shared among the network and
employed to streamline and standardize management across sites.
WCM and the RBM unit is fully committed to supporting the ACE program with full transparency
and accountability. The WCM led AFMC will submit formal quarterly reports to NIAID through the
ACE program staff and prepare annual progress reports. The report format will include detailed
financial data for each subcontract. We are committed to maintaining a strong line of
communication between the AFMC, the ACE Steering Committee and NIAID.

## Key facts

- **NIH application ID:** 10845038
- **Project number:** 2U19AI144301-06
- **Recipient organization:** WEILL MEDICAL COLL OF CORNELL UNIV
- **Principal Investigator:** Maria Virginia Pascual
- **Activity code:** U19 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $189,515
- **Award type:** 2
- **Project period:** 2019-05-01 → 2029-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10845038

## Citation

> US National Institutes of Health, RePORTER application 10845038, Funds Mgmt Core (2U19AI144301-06). Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/grant/nih/10845038. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*